Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza A virus | 3 | 2019 | 2234 | 0.88 | Why? |
| Air Microbiology | 4 | 2020 | 1322 | 0.65 | Why? |
| Aerosols | 6 | 2021 | 5393 | 0.65 | Why? |
| Particle Size | 1 | 2020 | 1052 | 0.57 | Why? |
| Orthomyxoviridae | 2 | 2020 | 1168 | 0.53 | Why? |
| DNA, Viral | 2 | 2021 | 2521 | 0.52 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.49 | Why? |
| Bronchoscopy | 1 | 2020 | 991 | 0.47 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.45 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.45 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.45 | Why? |
| Particulate Matter | 2 | 2020 | 3249 | 0.42 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.42 | Why? |
| Influenza B virus | 1 | 2015 | 815 | 0.39 | Why? |
| Swine Diseases | 1 | 2019 | 1219 | 0.38 | Why? |
| Influenza, Human | 3 | 2019 | 10779 | 0.37 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.37 | Why? |
| Ventilators, Mechanical | 1 | 2021 | 2193 | 0.37 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.34 | Why? |
| Virus Diseases | 2 | 2021 | 3779 | 0.31 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.27 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2021 | 11367 | 0.24 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.24 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.23 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.23 | Why? |
| Optical Devices | 1 | 2020 | 17 | 0.22 | Why? |
| Swine | 2 | 2020 | 3352 | 0.21 | Why? |
| Quantum Dots | 1 | 2021 | 129 | 0.20 | Why? |
| Housing, Animal | 1 | 2019 | 53 | 0.20 | Why? |
| Pasteurization | 1 | 2020 | 102 | 0.20 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.19 | Why? |
| Luciferases | 1 | 2021 | 378 | 0.19 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.19 | Why? |
| Milk Banks | 1 | 2020 | 99 | 0.18 | Why? |
| Suction | 1 | 2020 | 297 | 0.18 | Why? |
| Mutation Rate | 1 | 2021 | 382 | 0.18 | Why? |
| Reassortant Viruses | 1 | 2020 | 287 | 0.18 | Why? |
| DNA, Complementary | 1 | 2020 | 568 | 0.18 | Why? |
| Bacterial Load | 1 | 2018 | 179 | 0.18 | Why? |
| Base Sequence | 3 | 2021 | 3581 | 0.18 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
| Genotyping Techniques | 1 | 2020 | 360 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.17 | Why? |
| Electrochemical Techniques | 1 | 2021 | 406 | 0.16 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.16 | Why? |
| Environmental Microbiology | 2 | 2018 | 575 | 0.16 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.16 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.16 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.14 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.14 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Patients' Rooms | 1 | 2018 | 675 | 0.13 | Why? |
| Ontario | 4 | 2021 | 1966 | 0.13 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.13 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.13 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.13 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.12 | Why? |
| Virion | 1 | 2021 | 1444 | 0.12 | Why? |
| Saliva | 4 | 2021 | 4679 | 0.12 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.12 | Why? |
| Smartphone | 2 | 2021 | 1840 | 0.12 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.11 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.11 | Why? |
| Nose | 1 | 2018 | 1093 | 0.11 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.11 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.11 | Why? |
| Milk, Human | 1 | 2020 | 956 | 0.11 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.11 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.11 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.11 | Why? |
| Hospitals, Teaching | 1 | 2019 | 1609 | 0.11 | Why? |
| Canada | 5 | 2021 | 6018 | 0.11 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.11 | Why? |
| Humans | 38 | 2021 | 930598 | 0.10 | Why? |
| Air Pollution, Indoor | 1 | 2019 | 816 | 0.10 | Why? |
| Point-of-Care Testing | 2 | 2021 | 2782 | 0.10 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.10 | Why? |
| Microbiota | 1 | 2020 | 1240 | 0.10 | Why? |
| Social Media | 2 | 2021 | 5798 | 0.10 | Why? |
| Equipment Contamination | 1 | 2018 | 1308 | 0.10 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.09 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.08 | Why? |
| Animals | 7 | 2021 | 78931 | 0.08 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| Biosensing Techniques | 1 | 2021 | 2116 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Community Health Services | 1 | 2015 | 1000 | 0.08 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.07 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.07 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.07 | Why? |
| Zoonoses | 1 | 2019 | 3034 | 0.07 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.07 | Why? |
| Pilot Projects | 1 | 2015 | 5182 | 0.06 | Why? |
| Chiroptera | 1 | 2018 | 3530 | 0.06 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.06 | Why? |
| Apoferritins | 1 | 2021 | 32 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
| Internet | 1 | 2020 | 6204 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| Nursing Homes | 1 | 2019 | 4155 | 0.06 | Why? |
| Buffers | 1 | 2021 | 82 | 0.06 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.06 | Why? |
| Limit of Detection | 2 | 2020 | 2698 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.05 | Why? |
| Occupational Exposure | 1 | 2019 | 4742 | 0.05 | Why? |
| Air Pollutants | 1 | 2018 | 3110 | 0.05 | Why? |
| Electrodes | 1 | 2021 | 203 | 0.05 | Why? |
| Biological Availability | 1 | 2021 | 388 | 0.05 | Why? |
| Middle Aged | 7 | 2020 | 270681 | 0.05 | Why? |
| Tissue Distribution | 1 | 2021 | 483 | 0.05 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.05 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.05 | Why? |
| Aged | 5 | 2020 | 215776 | 0.05 | Why? |
| Sampling Studies | 1 | 2020 | 386 | 0.05 | Why? |
| Air Pollution | 1 | 2018 | 3504 | 0.05 | Why? |
| DNA, Ribosomal | 1 | 2018 | 112 | 0.05 | Why? |
| Spores, Bacterial | 1 | 2018 | 45 | 0.05 | Why? |
| Male | 8 | 2021 | 367725 | 0.05 | Why? |
| Viral Plaque Assay | 1 | 2020 | 381 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.05 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Adult | 7 | 2020 | 244371 | 0.04 | Why? |
| Outpatients | 2 | 2021 | 3417 | 0.04 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.04 | Why? |
| Female | 7 | 2020 | 380317 | 0.04 | Why? |
| Bacterial Toxins | 1 | 2018 | 185 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Receptors, Cell Surface | 1 | 2020 | 586 | 0.04 | Why? |
| Epitope Mapping | 1 | 2021 | 1240 | 0.04 | Why? |
| Hydrogen Peroxide | 1 | 2021 | 680 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.03 | Why? |
| Cannula | 1 | 2020 | 750 | 0.03 | Why? |
| Mobile Applications | 2 | 2021 | 3032 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2020 | 925 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2018 | 12361 | 0.03 | Why? |
| Equipment Reuse | 1 | 2021 | 985 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.03 | Why? |
| Decontamination | 1 | 2021 | 1196 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Software | 1 | 2020 | 2501 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Models, Molecular | 1 | 2020 | 7616 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.02 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Mubareka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(333)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_